Medico Remedies Limited (MEDICO) - Total Assets
Based on the latest financial reports, Medico Remedies Limited (MEDICO) holds total assets worth Rs1.53 Billion INR (≈ $16.59 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Medico Remedies Limited cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Medico Remedies Limited - Total Assets Trend (2013–2026)
This chart illustrates how Medico Remedies Limited's total assets have evolved over time, based on quarterly financial data. See net assets of Medico Remedies Limited for net asset value and shareholders' equity analysis.
Medico Remedies Limited - Asset Composition Analysis
Current Asset Composition (March 2026)
Medico Remedies Limited's total assets of Rs1.53 Billion consist of 84.0% current assets and 16.0% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 1.2% |
| Accounts Receivable | Rs819.92 Million | 53.5% |
| Inventory | Rs300.16 Million | 19.6% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs364.00K | 0.0% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2013–2026)
This chart illustrates how Medico Remedies Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Medico Remedies Limited (MEDICO) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medico Remedies Limited's current assets represent 84.0% of total assets in 2026, an increase from 74.5% in 2013.
- Cash Position: Cash and equivalents constituted 1.2% of total assets in 2026, up from 1.1% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2013.
- Asset Diversification: The largest asset category is accounts receivable at 53.5% of total assets.
Medico Remedies Limited Competitors by Total Assets
Key competitors of Medico Remedies Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
|
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621
|
China | CN¥2.30 Billion |
|
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390
|
China | CN¥8.59 Billion |
|
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
|
China | CN¥925.41 Million |
|
Jw Pharmac
KO:001060
|
Korea | ₩605.27 Billion |
|
Kamada
TA:KMDA
|
Israel | ILA377.21 Million |
|
Samjin Pharm
KO:005500
|
Korea | ₩449.14 Billion |
Medico Remedies Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.66 | 1.70 | 1.54 |
| Quick Ratio | 1.27 | 1.23 | 1.16 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs512.75 Million | Rs397.14 Million | Rs205.84 Million |
Medico Remedies Limited - Advanced Valuation Insights
This section examines the relationship between Medico Remedies Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.77 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 28.1% |
| Total Assets | Rs1.53 Billion |
| Market Capitalization | $44.57 Million USD |
Valuation Analysis
Below Book Valuation: The market values Medico Remedies Limited's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Medico Remedies Limited's assets grew by 28.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Medico Remedies Limited (2013–2026)
The table below shows the annual total assets of Medico Remedies Limited from 2013 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs1.53 Billion ≈ $16.59 Million |
+28.05% |
| 2025-03-31 | Rs1.20 Billion ≈ $12.96 Million |
+24.54% |
| 2024-03-31 | Rs961.95 Million ≈ $10.40 Million |
+10.00% |
| 2023-03-31 | Rs874.48 Million ≈ $9.46 Million |
+14.78% |
| 2022-03-31 | Rs761.90 Million ≈ $8.24 Million |
+0.75% |
| 2021-03-31 | Rs756.21 Million ≈ $8.18 Million |
+0.47% |
| 2020-03-31 | Rs752.69 Million ≈ $8.14 Million |
-1.36% |
| 2019-03-31 | Rs763.09 Million ≈ $8.25 Million |
+28.50% |
| 2018-03-31 | Rs593.85 Million ≈ $6.42 Million |
+23.09% |
| 2017-03-31 | Rs482.46 Million ≈ $5.22 Million |
+5.93% |
| 2016-03-31 | Rs455.43 Million ≈ $4.93 Million |
+27.41% |
| 2015-03-31 | Rs357.44 Million ≈ $3.87 Million |
+14.42% |
| 2014-03-31 | Rs312.40 Million ≈ $3.38 Million |
+70.47% |
| 2013-03-31 | Rs183.26 Million ≈ $1.98 Million |
-- |
About Medico Remedies Limited
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics… Read more